Shenwan Hongyuan Sticks to Their Buy Rating for InnoCare Pharma Ltd. (9969)

Tip Ranks
2025.11.18 05:05
portai
I'm PortAI, I can summarize articles.

Shenwan Hongyuan analyst maintained a Buy rating on InnoCare Pharma Ltd. yesterday and set a price target of HK$19.00.Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow. InnoCare Pharma Ltd. has an analyst consensus of Strong Buy, with a price target consensus of HK$23.20.

Shenwan Hongyuan analyst maintained a Buy rating on InnoCare Pharma Ltd. yesterday and set a price target of HK$19.00.

Meet Your ETF AI Analyst

  • Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
  • Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.

InnoCare Pharma Ltd. has an analyst consensus of Strong Buy, with a price target consensus of HK$23.20.

Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.